SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-037861
Filing Date
2024-04-30
Accepted
2024-04-30 16:21:49
Documents
18
Period of Report
2024-04-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0204892-8k_citius.htm   iXBRL 8-K 37743
2 FORM OF INVESTOR WARRANT ISSUED ON APRIL 30, 2024 ea020489201ex4-1_citius.htm EX-4.1 96175
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea020489201ex5-1_citius.htm EX-5.1 10609
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 25, 2024, BY AND AMONG ea020489201ex10-1_citius.htm EX-10.1 214752
5 PRESS RELEASE, DATED APRIL 26, 2024 ea020489201ex99-1_citius.htm EX-99.1 11382
6 PRESS RELEASE, DATED APRIL 30, 2024 ea020489201ex99-2_citius.htm EX-99.2 9496
  Complete submission text file 0001213900-24-037861.txt   651009

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ctxr-20240425.xsd EX-101.SCH 3027
8 XBRL LABEL FILE ctxr-20240425_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE ctxr-20240425_pre.xml EX-101.PRE 22367
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0204892-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 24897618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)